DOAJ
Open Access
2021
948 Final results from AIPAC: A phase IIb comparing eftilagimod alpha (a soluble LAG-3 protein) vs. placebo in combination with weekly paclitaxel in HR+ HER2- MBC
Christian Mueller
Frederik Marmé
Luc Dirix
Frederic Triebel
Hans Wildiers
+12 lainnya
Topik & Kata Kunci
Penulis (17)
C
Christian Mueller
F
Frederik Marmé
L
Luc Dirix
F
Frederic Triebel
H
Hans Wildiers
P
Peter Vuylsteke
C
Chrystelle Brignone
J
Jens Huober
S
Sherko Kümmel
A
Anne Armstrong
E
Eveline De Cuypere
F
Florence Dalenc
S
Steven Chan
C
Carolina Pia Schröder
J
Jean-Philippe Jacquin
E
Etienne Brain
Z
Zsuzsanna Pápai
Format Sitasi
Mueller, C., Marmé, F., Dirix, L., Triebel, F., Wildiers, H., Vuylsteke, P. et al. (2021). 948 Final results from AIPAC: A phase IIb comparing eftilagimod alpha (a soluble LAG-3 protein) vs. placebo in combination with weekly paclitaxel in HR+ HER2- MBC. https://doi.org/10.1136/jitc-2021-SITC2021.948
Akses Cepat
PDF tidak tersedia langsung
Informasi Jurnal
- Tahun Terbit
- 2021
- Sumber Database
- DOAJ
- DOI
- 10.1136/jitc-2021-SITC2021.948
- Akses
- Open Access ✓